Value of prostate-specific antigen density in predicting an upgrade in Gleason score for initial prostate biopsy

Chao Chen(Regeneron (United States)), Bo-hua Shen(First Affiliated Hospital Zhejiang University), Hejia Zhu(Zhejiang University), Xiangyi Zheng(Tianjin University), Liping Xie(First Affiliated Hospital Zhejiang University), Shuo Wang(Shenyang Pharmaceutical University)
Zhonghua miniao waike zazhi
October 15, 2013
10.3760/cma.j.issn.1000-6702.2013.10.010
Cited by 0

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188